Skip to content
AnalystLens

METLIFE INC 8-K Report, Regulation FD Disclosure (Dec 22, 2025)

Reports
Regulation FD
Filing Date
Filed December 22, 2025
Period End
December 22, 2025
In the record · 2016–202610-K1110-Q328-K249

MET filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 249 current reports (8-K) between 2016 and 2026.

  1. Deal closed8-K · Aug ’17Aug ’17
  2. Leadership change8-K · Mar ’23Mar ’23
  3. Leadership change8-K · Feb ’25Feb ’25

Summary

Summary of the 8-K filed December 22, 2025. Cited figures are marked; the original filing is the authoritative source.

MetLife, Inc. has filed an 8-K report to provide investors with a preliminary update on its financial performance and outlook for the fiscal year ending December 31, 2025, ahead of its official earnings release.

The company anticipates variable investment income for the fourth quarter of 2025 to be between $385 milliona and $435 million (pre-tax), slightly below its quarterly target of $425 million, but expects its full-year 2025 variable investment income to be around $1.7 billion (pre-tax). In terms of capital management, MetLife is prioritizing organic growth, with an estimated $4 billion deployed in 2025, and an additional $1 billion for M&A, including the pending acquisition of PineBridge Investments.

The company also expects to repurchase approximately $2.85 billionb of its common stock in 2025, a level it anticipates maintaining in 2026. Investors should note that this information is preliminary and unaudited, and actual results could materially differ.

Key Highlights

  1. MetLife is providing preliminary unaudited results and outlook for Q4 and full-year 2025.
  2. Estimated Q4 2025 variable investment income is projected at $385 million to $435 million (pre-tax), below the $425 million target.
  3. Full-year 2025 variable investment income is anticipated to be approximately $1.7 billion (pre-tax).
  4. The company projects a 7.7% return on its private equity portfolio for full-year 2025.
  5. MetLife anticipates a 9% annual return on its private equity portfolio for its 2026 outlook, contributing to an estimated $1.6 billion in variable investment income.
  6. Capital deployment in 2025 includes $4 billion for organic growth and $1 billion for M&A, notably the PineBridge acquisition.
  7. Total common stock repurchases for 2025 are estimated at $2.85 billion, with a similar level expected in 2026.

Frequently Asked Questions

  1. What is the key takeaway regarding MetLife's variable investment income for Q4 2025?

    MetLife anticipates its variable investment income for the fourth quarter of 2025 to be in the range of $385 million to $435 million (pre-tax). This preliminary estimate is slightly below the company's internal quarterly target of $425 million.

  2. How is MetLife planning to deploy its capital in 2025?

    MetLife's capital deployment strategy in 2025 prioritizes organic growth, with an estimated $4 billion allocated. Additionally, approximately $1 billion is earmarked for merger and acquisition activities, including the funding for the anticipated closing of the PineBridge Investments acquisition.

  3. What is MetLife's outlook for common stock repurchases?

    For the full year 2025, MetLife expects to repurchase approximately $2.85 billion of its common stock, with about $430 million of that occurring in the fourth quarter. The company anticipates a similar level of common stock repurchases to continue in 2026.

  4. How should investors interpret the preliminary financial information provided?

    Investors should exercise caution as the information provided is preliminary, unaudited, and based on information available as of the filing date. Actual financial results could differ materially from these estimates. This preliminary data should not be seen as a substitute for audited financial statements or as an indicator of future performance.